Company profile: Syra Health
1.1 - Company Overview
Company description
- Provider of healthcare and managed-care solutions grounded in real-world evidence and insights, including a mental and behavioral health platform for assessments, education, symptom monitoring, and interventions; an EMR to streamline clinical workflows and manage patient health information; a real-time patient engagement bot; workforce staffing and MSPs; a population health insights hub; and education and training.
Products and services
- CarePlus: An EMR-based system that streamlines clinical workflows, consolidates comprehensive patient health information, and aims to enhance operational efficiency, minimize errors, and improve patient care
- Population Health Insights Hub: A data hub-driven product that delivers public health data mining, vulnerability index calculation, disease-centric analysis, and predictive models for insights generation and risk prediction
- Syrenity: A digital mental and behavioral health system that offers targeted assessments, education, symptom monitoring, and care interventions to help prevent progression of negative factors influencing mental health
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Syra Health
WuXi XDC
HQ: China
Website
- Description: Provider of end-to-end CRDMO services for bioconjugates, including antibody-drug conjugates, spanning discovery, process development (scale-up, tech-transfer), analytical development, formulation/DP design, and GMP manufacturing of mAb intermediates and conjugations (antibodies and payload-linkers) from preclinical to commercial supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WuXi XDC company profile →
Biofer
HQ: Italy
Website
- Description: Provider of organic and inorganic medicinal chemicals and active pharmaceutical ingredients, including iron complexes for anemia, heparins and glycosaminoglycans as antithrombotics to prevent blood clots, steroids for anti-shock and antiallergic uses, folinates as antitumor adjuvants supporting cancer therapies, and enzymes as anti-inflammatories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biofer company profile →
Fortrea
HQ: United States
Website
- Description: Provider of comprehensive Phase I-IV clinical trial management, clinical pharmacology, patient access solutions, and other enabling services for biopharma and medical device and diagnostic companies, including medical device and diagnostic development, global regulatory submissions, and protocol development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fortrea company profile →
Bolder BioPath
HQ: United States
Website
- Description: Provider of pharmacology and pathology services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bolder BioPath company profile →
hVIVO
HQ: Ireland
Website
- Description: Provider of niche CRO pharmaceutical services specializing in human challenge clinical trials to test vaccines and antivirals for infectious and respiratory diseases, operating Europe’s only 24-bedroom quarantine clinic with onsite virology. Offers clinical trial design and execution, lab assays, and tech-enabled volunteer recruitment (including FluCamp), alongside ESG initiatives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full hVIVO company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Syra Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Syra Health
2.2 - Growth funds investing in similar companies to Syra Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Syra Health
4.2 - Public trading comparable groups for Syra Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →